Shebeen Attendees Perceptions of HIV Pre-Exposure Prophylaxis (PrEP) in KwaZulu-Natal Province, South Africa

Similar documents
Shebeens offer opportunity for HIV testing among high risk young men and women

Daily short message service surveys detect greater HIV risk behavior than monthly clinic questionnaires in Kenya

AIDS-RELATED STIGMA, HIV TESTING, AND TRANSMISSION RISK IN CAPE TOWN, SOUTH AFRICA

COMMUNITY SYSTEMS TOOLBOX COMMUNITY SYSTEMS STRENGTHENING. Increasing access to quality health and social services. Building strong communities.

PrEP: Pre-Exposure Prophylaxis to Prevention HIV Infection

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination

Informed Consent Flipchart. Version 1.0, 30 Jan 2018

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?

If you are a man that ONLY has sex with women this may not be the brochure for you.

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF

Using anti-hiv drugs for prevention

Fulton County Board of Health Strategy to End the HIV Epidemic in Fulton County

Factors influencing adherence behavior for daily and intermittent regimens of PrEP among MSM in Kenya

Chart Pack National Survey of Young Adults on HIV/AIDS

NATIONAL SURVEY OF YOUNG ADULTS ON HIV/AIDS

PrEP in young African women: Rationale & lessons from HPTN 082

HIV/AIDS MODULE. Rationale

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

HIV Pre- Exposure Prophylaxis

CARE FOR HIV PATIENTS IN RURAL SOUTH AFRICA

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect

A Daily Pill to Prevent HIV: Oral Pre-exposure Prophylaxis (PrEP)

HIV Testing Survey, 2002

Performance Management Plan Indicator Worksheet #1

Program to control HIV/AIDS

Dr. Madhombiro. Department of Psychiatry UZ College of Health Sciences

Implementation of PrEP in Kenya

Acceptability of HPTN 077. The George Washington University HPTN Clinical Research Site 16 June 2016

National Survey of Young Adults on HIV/AIDS

Amanda D. Castel, MD, MPH Assistant Professor George Washington University School of Public Health and Health Services

Public Attitudes and Knowledge about HIV/AIDS in Georgia Kaiser Family Foundation

PrEP for Women: HIV Prevention in Family Planning Settings

PROVIDERS VIEWS ON PREP FOR ADOLESCENT GIRLS AND YOUNG WOMEN IN TANZANIA

HIV Prevention Pearls

HIV and the Buckeye State

Nikhil Prachand, MPH Britt Skaathun

Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention

Overview November 2017

PrEP for Women. Together, we can change the course of the HIV epidemic one woman at a time.

A Sub-Study Comparing Acceptability and Adherence of Daily or Non-Daily Pre-Exposure Regimens Between Young and Older South African Women

CROI 2015: HIV Prevention Updates

HIV Prevention Service Provider Survey 2014

HIV Knowledge and Awareness

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

Combination prevention: Public health and human rights imperatives

Providing Good Care to People Living with HIV

Options in HIV Prevention A Participant-Centered Counseling Approach

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

The Science behind Preexposure Prophylaxis (PrEP) Yunus Moosa Department of Infectious Diseases UKZN

The Open Label Trial Past and Present

The Open Label Trial Past and Present

Knowledge, Attitudes and Behavior Related to HIV/AIDS among Transport Sector Workers

About FEM-PrEP. FEM-PrEP is also studying various behaviors, clinical measures, and health outcomes among the trial s participants.

11/8/2016. The Challenge of HIV Treatment

Good care for people with HIV. Rights and Wrongs. Jane Anderson. May 2013

An evaluation of the STD profiles and safe sex practices of a sample of swingers

Wiltshire Children and Young People s Health and Wellbeing Survey 2015: Risky behaviours

Pre-Exposure Prophylaxis (PrEP) 1 Prevention of HIV in At-Risk Women:

PrEP in young African women: Rationale & lessons from HPTN 082 (and other studiesp

The impact of religion, culture, and multiple stigmas on HIV prevention with Men who have Sex with Men in Sub-Saharan Africa. Thomas Agyarko-Poku

National HIV self-sampling service

PrEP (Pre-Exposure-Prophylaxis) for sub-saharan African migrants in Europe?

HIV/AIDS Prevalence Among South African Health Workers, 2002

SYNDROMIC CASE MANAGEMENT OF STD

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

Visibility, Attitudes and Opinions of the PrEP Campaign in NYC

Understanding the Results of VOICE

Overcoming Structural Barriers to HIV Prevention

AIDS. health concern. As of 2005, a cure for HIV/AIDS remains to be found. While medical

Adolescents and HIV in 2018: No Youth Left Behind

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London

Progress against the HIV Epidemic: is the end in sight?

HIV and AIDS Estimates

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep

Government of Canada Federal AIDS Initiative Milestones

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE

IAPAC Summit Daily And Intermittent PrEP

PrEP and Behavioral Strategies for HIV Prevention. Douglas Krakower, MD January 30, 2014

BOTSWANA INTERNATIONAL HIV CONFERENCE: PREVENTION IS THE WAY FORWARD

Influence of STIs on Condom Use Behavior in College Age Women

Click to edit Master title style. Unintended Pregnancy: Prevalence. Unintended Pregnancy: Risk Groups. Unintended Pregnancy: Consequences 9/23/2015

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health

PRE-EXPOSURE PROPHYLAXIS FOR HIV: EVIDENCE AND GENDER CONSIDERATIONS. Jean R. Anderson M.D. Director, Johns Hopkins HIV Women s Health Program

WORLD AIDS DAY HIV in the UK Let s End It. World AIDS Day is celebrated annually on 1st December. Produced by NAT (National AIDS Trust)

5/29/2013 HIV/STD RECOGNITION AND PREVENTION. Debbie Tristram, MD Professor of Pediatrics Albany Medical College

Orphanhood, Gender, and HIV Infection among Adolescents in South Africa: A Mixed Methods Study

MANITOBA HIV REPORT 2015

A guide to protecting your partner from HIV transmission Information for patients

YOU ARE NOT ALONE Health and Treatment for HIV Positive Young Men of Color

HIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013

HIV PREVENTION. ETHICAL CONSIDERATIONS IN DEVELOPING AN EVIDENCE BASE FOR PrEP IN PREGNANT WOMEN

ADOLESCENT SEXUALITY - SHS Anonymous Survey Results Heather Johnson

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs

ViiV Healthcare s Position on Prevention in HIV

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

Introduction. Relationships. Condoms. HIV Testing. DC HIV Behavior Study #1. Here is what we learned:

Transcription:

Shebeen Attendees Perceptions of HIV Pre-Exposure Prophylaxis (PrEP) in KwaZulu-Natal Province, South Africa Katie Kuenzle Yale University Philanjalo

Background: HIV Prevalence South Africa has the largest global HIV epidemic 6.3 million people living with HIV 19.2% among adults 1 in KZN Mainly heterosexual epidemic 2 Alcohol use increases HIV risk 2 Oral Pre-exposure prophylaxis (PrEP) is an effective prevention strategy that reduces the risk of contracting and transmitting HIV 2 PrEP is Truvada (TDF/FTC) once daily pill PrEP Efficacy: 92-99% Effectiveness depends on adherence which has varied among studies South Africa: PrEP is currently approved for sex workers and MSM

Background: PrEP Young men and women who consume excess alcohol are an increasingly recognized high risk population PrEP is effective and efficient in injection drug users 2 No data on PrEP and alcohol use Previous Studies 2015: 200 community members in Msinga were surveyed on their perception and acceptance of PrEP > 90% were interested in PrEP 2016: 503 shebeen attendees participated in outreach HIV testing 8.5% were HIV+, disproportionately affecting women High rates of lack of condom use (20%) and multiple partners (30%)

Objectives This study aims to Identify and understand the perceptions of HIV risk and interest in PrEP among shebeen attendees in a rural and resource limited, highly HIV prevalent region of South Africa Understand the perceptions of the shebeen attendees on the role their alcohol and marijuana use plays in their participation in risky behaviors and ability to use PrEP/other methods of HIV prevention

Methods Rural Msinga subdistrict of the Umzinyathi district in the KwaZulu-Natal province of South Africa Anonymous quantitative questionnaires Shebeen attendees were eligible if > 18 yo and lived within the Umzinyathi district Questionnaires were conducted in Zulu by a trained research staff member Attendees were approached outside shebeens, prior to alcohol consumption

Study Population Characteristics (n = 180) 180 questionnaires were conducted in 21 shebeens over 8 weeks Demographics N (%) Men 162 (90.0%) Women 18 (10.0%) Median Age 29.6 years Employed 95 (53.1%) Family Member with Grant 158 (87.8%) Completed Secondary School 172 (96%) Electricity 161 (89.4%)

Perceived HIV Risk Perceived HIV Risk Yes N (%) Getting HIV can be avoided 174 (96.7%) Worry about getting sick with HIV 178 (98.9%) HIV is a serious disease 170 (94.4%) Know someone who is sick with HIV 156 (86.7%) Know someone who has died from HIV 145 (80.6%) Person who suggests condom use 169 (93.9%) Easy to reject sexual advances 143 (79.4%) In heat of passion, difficult time using condoms 166 (92.2%)

Assessment of Personal HIV Risk Personal HIV Risk Yes N (%) Have you had sex in the past month? 157 (87.2%) Do you believe your partners have had sex with others in the past month? 6 (3.3%) Do you believe any of your past or present partners have had HIV? 23 (14.6%) Has anyone ever paid you for sex? 1 (0.6%) Have you ever paid anyone for sex? 18 (10.3%)

Sexual Partners and Condom Use Number of Sexual Partners in the Past Month Among Shebeen Attendees 3 partners Condom Use Among Shebeen Attendees Never 6% Always 0.56% 2 partners 1 partner 66% Less than half the time 29% More than half the time 65%

Alcohol Use Gender Proportion with Elevated AUDIT Score N (%) Male 75 (57.7%) 11.7 Female 11 (68.7%) 7.7 Total 86 (58.9%) 11.2 Mean AUDIT Score An AUDIT score of 8 or higher for men and 4 or higher in women indicates hazardous alcohol consumption

Marijuana Use Marijuana Use Among Shebeen N (%) or mean (std. dev) Attendees Smoked Marijuana 27 (15.0%) Smoked Marijuana in past week 27 (100.0%) * Number of Days in past week Smoked 6.6 Marijuana Severity Dependence Scale (SDS) 6.2 (STD 3.9) Score Cannabis Abuse Screening Test 10.2 (STD 5.0) (CAST) Score *Percentages were calculated from population who has smoked marijuana A SDS score of 4 or higher indicates cannabis dependence A CAST score of 6 or higher indicates cannabis use disorder

Stigma and Interest Surrounding PrEP PrEP Stigma Yes N (%) If you were taking PrEP, others would think less of 35 (19.6%) you If you were taking PrEP, others would avoid you 19 (10.6%) If you were taking PrEP, others would think you have HIV 172 (98.9%) If you were taking PrEP, you would feel comfortable 169 (93.9%) telling others PrEP Stigma Yes N (%) Are you interested in taking PrEP? 178 (99.4%) Would you take PrEP even if it did not protect you 168 (93.9%) 100% from getting HIV? Would you take PrEP daily in order for it to work? 153 (85.5%)

Perceived Benefits and Barriers to PrEP Perceived Benefits and Barriers Yes N (%) I prefer to avoid getting HIV by taking PrEP now 179 (100.0%) I would set a good example if I took meds to 172 (96.1%) prevent HIV If I take PrEP, others will think I have HIV 166 (92.7%) My fear of side effects prevents me from being interested in PrEP 41 (22.9%) Traveling to the clinic is too expensive 65 (36.3%) I would only go to the clinic if I was sick 164 (91.6%) I am concerned that my alcohol use will prevent me from taking PrEP 4 (2.7%) I am concerned that my marijuana use will prevent me from taking PrEP 1 (4.0%)

Alcohol Use and HIV Risk Correlates of Alcohol Use Disorder Chi Square P Value Previous HIV Test 0.96 Worried about HIV 0.23 Number of Partners 0.92

Marijuana Use and HIV Risk Correlates of Marijuana Use Disorder Chi Square P Value Previous HIV Test 0.11 Worried about HIV 0.55 Condom Use 0.65 Number of Partners 0.05

Discussion There is a high level of interest in PrEP among shebeen attendees in rural South Africa Shebeen attendees Report engaging in HIV risk behaviors Report being worried about acquiring HIV and interested in PrEP Report excess alcohol use and dependence Report marijuana dependence

Discussion continued Potential barriers to implementing PrEP in this high risk population include: Stigma surrounding HIV and PrEP The expense of traveling to the clinic for monthly check-ins Unrecognized impact of alcohol and marijuana use

Limitations of the Study Cross sectional survey Shebeen attendees are newly informed about PrEP No knowledge of shebeen attendees HIV status

Conclusion High levels of marijuana use are associated with HIV risk behaviors in rural South Africa Important to recognize those with alcohol use and marijuana use disorders as an important population for HIV prevention initiatives Future directions: Demonstrate feasibility of initiating PrEP and maintaining short term adherence among those drinking alcohol

References [1] HIV and AIDS in south africa. (2016). Retrieved from http://www.avert.org/professionals/hiv-around-world/sub-saharanafrica/south-africa [2] Targeting alcohol venues to engage high-risk individuals for HIV prevention services in rural south africa. (2016). Unpublished manuscript. [3]Baeten, J.M., Donnell, D., Ndase, P., Mugo, J.D., Campbell, J., Wangisi, J.W., & Celum, C. (2012) Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. The New England Journal of Medicine, 367, 399-410.

Acknowledgements Malusi Gasa Dr. Anthony Moll and the Staff at the ARV Clinic Dr. Sheela Shenoi